Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model.

Saved in:
Bibliographic Details
Title: Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model.
Authors: Li, Xuehua1, Zhong, Yingkui1,2, Yuan, Chenglang3, Lin, Jinjiang1, Shen, Xiaodi1, Guo, Minyi4, Lu, Baolan1, Meng, Jixin1, Wang, Yangdi1, Zhang, Naiwen3, Luo, Zixin3, Hu, Guimeng3, Mao, Ren5, Chen, Minhu5, Sun, Canhui1, Li, Ziping1, Cao, Qing‐hua6, Chen, Baili5, chenbail@mail.sysu.edu.cn, Chen, Zhihui7, chzhhui@mail.sysu.edu.cn, Huang, Bingsheng3, huangb@szu.edu.cn
Source: International Journal of Intelligent Systems; Dec2022, Vol. 37 Issue 12, p11853-11870, 18p
Database: Applied Science & Technology Source
Full text is not displayed to guests.
Description
ISSN:08848173
DOI:10.1002/int.23066